Form 4: Organon Director Ramona Sequeira Granted Over 21,000 Phantom Stock Units

Organon & Co. Director Ramona Sequeira was granted 21,890.547 phantom stock units, effective July 1, 2025, as part of the company's Non-Employee Director Savings Plan.

Summary

• Ramona Sequeira, a Director at Organon & Co. (OGN), acquired 21,890.547 phantom stock units.
• The transaction date for this acquisition is July 1, 2025.
• Each phantom stock unit is an economic equivalent of one share of Organon common stock.
• The phantom stock units were granted under the Organon Non-Employee Director Savings Plan.
• These units are payable in cash upon settlement after the director's termination of service, according to the terms of the Plan.
• The price of the derivative security (phantom stock) is $10.05.
• Following this transaction, Ramona Sequeira beneficially owns 21,890.547 phantom stock units directly.

Sentiment

Score: 5

Explanation: The document reports a routine compensation grant to a director, which is a neutral event in terms of company performance or outlook.

Positives

• The grant of phantom stock units aligns the financial interests of Director Ramona Sequeira with the long-term performance of Organon & Co. common stock.

Industry Context

This is a standard director compensation mechanism employed by many publicly traded companies, including those in the pharmaceutical sector, to align the incentives of non-employee directors with shareholder value creation.

Comparison to Industry Standards

• Phantom stock grants are a common form of non-employee director compensation across various industries, including pharmaceuticals. The specific value and number of units would require comparison to peer companies like Merck, Pfizer, or Bristol Myers Squibb to assess if it is above or below average, but the document does not provide enough information for this specific comparison.

Corporate Governance

Related Party Transactions

• The grant of phantom stock units to Ramona Sequeira, a Director, constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with shareholder value, as the phantom stock's value is tied to the common stock price.

Next Steps

• Phantom stock units will be settled in cash upon the director's termination of service, as per the plan terms.

Key Dates

Keywords

Organon & Co., OGN, Ramona Sequeira, Form 4, SEC filing, insider transaction, phantom stock, director compensation, equity grant, corporate governance